GMO Research & AI, Inc. (TYO:3695)

GMO Research & AI Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	213	248	428	458	385	240
Depreciation & Amortization	109	104	89	85	68	70
Other Operating Activities	-46	-78	-140	-169	-86	-66
Change in Accounts Receivable	197	45	196	-170	-141	33
Change in Inventory	7	9	3	-22	-6	9
Change in Accounts Payable	-90	-13	-95	83	165	15
Change in Other Net Operating Assets	-6	-78	-6	-134	97	62
Operating Cash Flow	419	237	475	131	482	363
Operating Cash Flow Growth	-11.42%	-50.10%	262.60%	-72.82%	32.78%	146.94%
Capital Expenditures	-1	-1	-	-3	-10	-1
Sale (Purchase) of Intangibles	-101	-123	-120	-88	-65	-93
Investment in Securities	-29	-46	-9	-17	25	4
Other Investing Activities	-	-51	-2	-3	-	-5
Investing Cash Flow	-131	-221	-131	-111	-50	-95
Dividends Paid	-187	-187	-178	-137	-87	-68
Other Financing Activities	-5	-8	-9	-8	-9	-14
Financing Cash Flow	-192	-195	-187	-145	-96	-82
Foreign Exchange Rate Adjustments	-32	33	11	27	16	-
Miscellaneous Cash Flow Adjustments	257	-	-1	1	-1	-1
Net Cash Flow	321	-146	167	-97	351	185
Free Cash Flow	418	236	475	128	472	362
Free Cash Flow Growth	-11.44%	-50.32%	271.09%	-72.88%	30.39%	147.94%
Free Cash Flow Margin	7.30%	4.70%	9.28%	2.46%	11.55%	10.67%
Free Cash Flow Per Share	179.40	144.45	290.77	78.39	289.13	221.73
Cash Income Tax Paid	46	78	139	168	87	66
Levered Free Cash Flow	433.38	39.88	306.63	-38.5	397.63	258.38
Unlevered Free Cash Flow	433.38	39.88	306.63	-38.5	397.63	258.38
Change in Working Capital	108	-37	98	-243	115	119

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.